4//SEC Filing
Kakkar Rahul 4
Accession 0000899243-21-005689
CIK 0001807901other
Filed
Feb 9, 7:00 PM ET
Accepted
Feb 10, 4:47 PM ET
Size
5.7 KB
Accession
0000899243-21-005689
Insider Transaction Report
Form 4
Kakkar Rahul
DirectorChief Executive Officer
Transactions
- Award
Stock Option (right to buy)
2021-02-08+221,367→ 221,367 totalExercise: $17.75Exp: 2031-02-07→ Common Stock (221,367 underlying)
Footnotes (1)
- [F1]This option award was granted on February 8, 2021. 1/4 of the shares underlying the award shall vest on February 8, 2022, with the remainder of the shares vesting in equal monthly installments following February 8, 2022 through February 8, 2025, subject to the reporting person's continued service on each applicable vesting date.
Documents
Issuer
Pandion Therapeutics, Inc.
CIK 0001807901
Entity typeother
Related Parties
1- filerCIK 0001817416
Filing Metadata
- Form type
- 4
- Filed
- Feb 9, 7:00 PM ET
- Accepted
- Feb 10, 4:47 PM ET
- Size
- 5.7 KB